Phase I/II Trial of Valproic Acid and Carnitine in Infants With Spinal Muscular Atrophy Type I (CARNI-VAL Type I)
Phase I/II Trial of Valproic Acid and Carnitine in Infants With Spinal Muscular Atrophy Type I (CARNI-VAL Type I) is a PHASE1 clinical asset sponsored by University of Utah in Spinal Muscular Atrophy Type I. SEO and diligence focus: Valproic Acid and Levocarnitine, endpoint relevance, enrollment feasibility, competitive positioning, readout timing and IP durability.
Indication: Spinal Muscular Atrophy Type I
Modality: small molecule
Target: Valproic Acid and Levocarnitine
Sponsor: University of Utah
Source URL: ClinicalTrials.gov
Source updated: Detailed source ingestion pending
Ingested: Jul 23, 2026
Model: trialsignal-ai-v1
Validation: validated
Matched by target_normalized: Valproic Acid and Levocarnitine
View original source fields
Condition raw: Spinal Muscular Atrophy Type I
Condition normalized: Spinal Muscular Atrophy Type I
Modality raw: small molecule
Modality normalized: small molecule
Target raw: Valproic Acid and Levocarnitine
Target normalized: Valproic Acid and Levocarnitine